1. Home
  2. HQH vs AMPH Comparison

HQH vs AMPH Comparison

Compare HQH & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo abrdn Healthcare Investors Shares of Beneficial Interest

HQH

abrdn Healthcare Investors Shares of Beneficial Interest

HOLD

Current Price

$19.41

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$20.92

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HQH
AMPH
Founded
1986
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
HQH
AMPH
Price
$19.41
$20.92
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$28.38
AVG Volume (30 Days)
153.0K
414.9K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
11.56%
N/A
EPS Growth
N/A
N/A
EPS
1.09
2.03
Revenue
N/A
$719,887,000.00
Revenue This Year
N/A
$6.90
Revenue Next Year
N/A
$4.64
P/E Ratio
$17.96
$10.25
Revenue Growth
N/A
N/A
52 Week Low
$15.09
$17.03
52 Week High
$20.46
$31.26

Technical Indicators

Market Signals
Indicator
HQH
AMPH
Relative Strength Index (RSI) 56.61 47.70
Support Level $18.61 $20.41
Resistance Level $19.57 $22.90
Average True Range (ATR) 0.31 0.83
MACD 0.08 0.15
Stochastic Oscillator 67.93 26.71

Price Performance

Historical Comparison
HQH
AMPH

About HQH abrdn Healthcare Investors Shares of Beneficial Interest

abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: